Related references
Note: Only part of the references are listed.Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice
Karin H. Nilsson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2021)
RSPO3 is important for trabecular bone and fracture risk in mice and humans
Karin H. Nilsson et al.
NATURE COMMUNICATIONS (2021)
Chondrocytes in the resting zone of the growth plate are maintained in a Wnt-inhibitory environment
Shawn A. Hallett et al.
ELIFE (2021)
Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics
Jonas Bovijn et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Osteoblast-derived NOTUM reduces cortical bone mass in mice and the NOTUM locus is associated with bone mineral density in humans
Sofia Moverare-Skrtic et al.
FASEB JOURNAL (2019)
An atlas of genetic influences on osteoporosis in humans and mice
John A. Morris et al.
NATURE GENETICS (2019)
NOTUM inhibition increases endocortical bone formation and bone strength
Robert Brommage et al.
BONE RESEARCH (2019)
Regulation of Bone Metabolism by Sex Steroids
Sundeep Khosla et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis
Anne Sophie Koldkjaer Solling et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2018)
RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6
Emmanuelle Szenker-Ravi et al.
NATURE (2018)
Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study
Katerina Trajanoska et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Romosozumab for the treatment of osteoporosis
Leonardo Bandeira et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and Obesity
Carmelo Quarta et al.
CELL METABOLISM (2017)
Role and mechanism of action of sclerostin in bone
Jesus Delgado-Calle et al.
BONE (2017)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The role of membrane ERα signaling in bone and other major estrogen responsive tissues
K. L. Gustafsson et al.
SCIENTIFIC REPORTS (2016)
The WNT system: background and its role in bone
U. H. Lerner et al.
JOURNAL OF INTERNAL MEDICINE (2015)
The bone-sparing effects of estrogen and WNT16 are independent of each other
Sofia Moverare-Skrtic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Multiple Doses of Sclerostin Antibody Romosozumab in Healthy Men and Postmenopausal Women With Low Bone Mass: A Randomized, Double-Blind, Placebo-Controlled Study
Desmond Padhi et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
Sofia Moverare-Skrtic et al.
NATURE MEDICINE (2014)
Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-κB
Bo Yu et al.
NATURE MEDICINE (2014)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
A conditional allele of Rspo3 reveals redundant function of R-spondins during mouse limb development
Stanley Neufeld et al.
GENESIS (2012)
FGF/FGFR signaling in bone formation: Progress and perspectives
Pierre J. Marie et al.
GROWTH FACTORS (2012)
Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives
Roland Baron et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling
Andrei Glinka et al.
EMBO REPORTS (2011)
Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
Wim de Lau et al.
NATURE (2011)
R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling
Kendra S. Carmon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Glucocorticoids Suppress Bone Formation by Attenuating Osteoblast Differentiation via the Monomeric Glucocorticoid Receptor
Alexander Rauch et al.
CELL METABOLISM (2010)
Update on Estrogens and the Skeleton
Sundeep Khosla
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
R-spondin3 is required for mouse placental development
Motoko Aoki et al.
DEVELOPMENTAL BIOLOGY (2007)
Regulation of osteoblastogenesis and bone mass by Wnt10b
CN Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Epidemiology of osteoporotic fractures
Olof Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
High bone density due to a mutation in LDL-receptor-related protein 5
LM Boyden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
